310 related articles for article (PubMed ID: 8168635)
1. Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Therapeutic intervention by immunostimulation?
Rabinovitch A
Diabetes; 1994 May; 43(5):613-21. PubMed ID: 8168635
[TBL] [Abstract][Full Text] [Related]
2. Cellular and molecular pathogenic mechanisms of insulin-dependent diabetes mellitus.
Yoon JW; Jun HS
Ann N Y Acad Sci; 2001 Apr; 928():200-11. PubMed ID: 11795511
[TBL] [Abstract][Full Text] [Related]
3. An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus.
Rabinovitch A
Diabetes Metab Rev; 1998 Jun; 14(2):129-51. PubMed ID: 9679667
[TBL] [Abstract][Full Text] [Related]
4. Contribution of T cells to the development of autoimmune diabetes in the NOD mouse model.
Toyoda H; Formby B
Bioessays; 1998 Sep; 20(9):750-7. PubMed ID: 9819564
[TBL] [Abstract][Full Text] [Related]
5. A glutamic acid decarboxylase 65-specific Th2 cell clone immunoregulates autoimmune diabetes in nonobese diabetic mice.
Tisch R; Wang B; Atkinson MA; Serreze DV; Friedline R
J Immunol; 2001 Jun; 166(11):6925-36. PubMed ID: 11359854
[TBL] [Abstract][Full Text] [Related]
6. Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus.
Rabinovitch A; Suarez-Pinzon WL
Biochem Pharmacol; 1998 Apr; 55(8):1139-49. PubMed ID: 9719467
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune disorders in diabetes.
Boitard C; Debray-Sachs M; Bach JF
Adv Nephrol Necker Hosp; 1986; 15():281-305. PubMed ID: 3082114
[TBL] [Abstract][Full Text] [Related]
8. Th1 to Th2 cytokine shifts in nonobese diabetic mice: sometimes an outcome, rather than the cause, of diabetes resistance elicited by immunostimulation.
Serreze DV; Chapman HD; Post CM; Johnson EA; Suarez-Pinzon WL; Rabinovitch A
J Immunol; 2001 Jan; 166(2):1352-9. PubMed ID: 11145720
[TBL] [Abstract][Full Text] [Related]
9. NK T cell-induced protection against diabetes in V alpha 14-J alpha 281 transgenic nonobese diabetic mice is associated with a Th2 shift circumscribed regionally to the islets and functionally to islet autoantigen.
Laloux V; Beaudoin L; Jeske D; Carnaud C; Lehuen A
J Immunol; 2001 Mar; 166(6):3749-56. PubMed ID: 11238616
[TBL] [Abstract][Full Text] [Related]
10. T-cell regulation in murine and human autoimmune diabetes: the role of TH1 and TH2 cells.
Heurtier AH; Boitard C
Diabetes Metab; 1997 Nov; 23(5):377-85. PubMed ID: 9416429
[TBL] [Abstract][Full Text] [Related]
11. Studies on autoimmunity for initiation of beta-cell destruction. X. Delayed expression of a membrane-bound islet cell-specific 38 kDa autoantigen that precedes insulitis and diabetes in the diabetes-prone BB rat.
Ko IY; Jun HS; Kim GS; Yoon JW
Diabetologia; 1994 May; 37(5):460-5. PubMed ID: 8056182
[TBL] [Abstract][Full Text] [Related]
12. Both CD4+ and CD8+ T-cells in syngeneic islet grafts in NOD mice produce interferon-gamma during beta-cell destruction.
Suarez-Pinzon W; Rajotte RV; Mosmann TR; Rabinovitch A
Diabetes; 1996 Oct; 45(10):1350-7. PubMed ID: 8826970
[TBL] [Abstract][Full Text] [Related]
13. Deviation of pancreas-infiltrating cells to Th2 by interleukin-12 antagonist administration inhibits autoimmune diabetes.
Trembleau S; Penna G; Gregori S; Gately MK; Adorini L
Eur J Immunol; 1997 Sep; 27(9):2330-9. PubMed ID: 9341777
[TBL] [Abstract][Full Text] [Related]
14. Early Th1 response in unprimed nonobese diabetic mice to the tyrosine phosphatase-like insulinoma-associated protein 2, an autoantigen in type 1 diabetes.
Trembleau S; Penna G; Gregori S; Magistrelli G; Isacchi A; Adorini L
J Immunol; 2000 Dec; 165(12):6748-55. PubMed ID: 11120794
[TBL] [Abstract][Full Text] [Related]
15. Induction of glutamic acid decarboxylase 65-specific Th2 cells and suppression of autoimmune diabetes at late stages of disease is epitope dependent.
Tisch R; Wang B; Serreze DV
J Immunol; 1999 Aug; 163(3):1178-87. PubMed ID: 10415012
[TBL] [Abstract][Full Text] [Related]
16. Cytokine gene expression in pancreatic islet-infiltrating leukocytes of BB rats: expression of Th1 cytokines correlates with beta-cell destructive insulitis and IDDM.
Rabinovitch A; Suarez-Pinzon W; El-Sheikh A; Sorensen O; Power RF
Diabetes; 1996 Jun; 45(6):749-54. PubMed ID: 8635648
[TBL] [Abstract][Full Text] [Related]
17. Cellular and molecular mechanisms for the initiation and progression of beta cell destruction resulting from the collaboration between macrophages and T cells.
Yoon JW; Jun HS; Santamaria P
Autoimmunity; 1998; 27(2):109-22. PubMed ID: 9583742
[TBL] [Abstract][Full Text] [Related]
18. Beta-cell destruction may be a late consequence of the autoimmune process in nonobese diabetic mice.
Shimada A; Charlton B; Taylor-Edwards C; Fathman CG
Diabetes; 1996 Aug; 45(8):1063-7. PubMed ID: 8690153
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms for gender differences in susceptibility to T cell-mediated autoimmune diabetes in nonobese diabetic mice.
Bao M; Yang Y; Jun HS; Yoon JW
J Immunol; 2002 May; 168(10):5369-75. PubMed ID: 11994496
[TBL] [Abstract][Full Text] [Related]
20. Initiation of autoimmune type 1 diabetes and molecular cloning of a gene encoding for islet cell-specific 37kd autoantigen.
Jun HS; Yoon JW
Adv Exp Med Biol; 1994; 347():207-20. PubMed ID: 7976732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
